Online ISSN: 2515-8260

Author : Bhat, Dr Swetha


EPIDEMIOLOGIC EVALUATION OF DIFFERENT PHARMACOTHERAPEUTIC TREATMENT MODALITIES FOR MANAGEMENT OF ORAL SUBMUCOUS FIBROSIS

Dr Swetha Bhat; Dr Senthilnathan Periasamy; Dr Murugaiyan Arun

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 927-935

senthilnathan@saveetha.com
3arunm.sdc@saveetha.com
ABSTRACT
The purpose of this study was to highlight various pharmacotherapeutic treatment modalities and to
compile them to assist in early intervention and management of Oral Submucous Fibrosis
This study was conducted on 92 patients who reported to the Department of Oral Surgery and Oral
Medicine, Saveetha Dental College, Chennai. They were clinically diagnosed with oral submucous with
standard data grading and were given a combination of treatments currently available. Out of 92 cases,
85(92.4%) were males and 7(7.6%) were females which showed a male predominance with a ratio of 12:1
in the prevalence of Oral Submucous Fibrosis. The age group affected the most was 35-50 years (54.28%).
Oral systemic antioxidants was prescribed to 54% of the patients and was the most frequently used
treatment modality in the pharmacotherapeutic management of Oral Submucous Fibrosis. Management of
Oral Submucous Fibrosis has been the subject of controversy ever since it was first stated in 1952. This
study attempts to compile the available treatment and its current status to assist early intervention of the
disease.